Sorry, you need to enable JavaScript to visit this website.
Skip to main content

Dexcom G6 is now covered by RAMQ, BC PharmaCare, and Saskatchewan Health


The Dexcom G6 CGM System is now covered in Québec by RAMQ, in British Columbia by BC PharmaCare, and in Saskatchewan by Saskatchewan Health. Conditions apply. Click the links below for more information.


Quebec (RAMQ)

British Columbia (BC PharmaCare)

Saskatchewan (Saskatchewan Health)

See how Dexcom products can help optimize your patients' glucose control and support a greater quality of life.

Why choose Dexcom G6 for your patients

Revolutionizing diabetes management Dexcom is dedicated to helping patients, and their healthcare teams, better manage their diabetes by developing innovative glucose sensing technology, software and products.
Smart devices not included

Redefining CGM and a new standard in diabetes management.

From "snapshot" glucose readings to continuous glucose monitoring (CGM) systems that provide around-the-clock data visibility,
Dexcom is defining a new chapter in diabetes therapy management with a revolutionary, no-fingerstick CGM system.*
Exceptional accuracy1
Improved glycemic outcomes
(multiple measures)2,3
Zero fingersticks* with Dexcom G6
Customizable high and low alerts
Shared glucose data, remote monitoring
Smart device compatibility§
* If your glucose alerts and readings from the Dexcom G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
† Requires the Follow App and an internet connection. Followers should always confirm readings on the Dexcom G6 App or Receiver before making treatment decisions
§ For a list of compatible devices, please visit dexcom.com/compatibility. Use of the smart watch requires the Dexcom G6 App on a compatible smartphone.
1 Shah VN, et al. Diabetes Technol Ther 2018;20:428-33.
2 Beck RW, et al. JAMA. 2017;317:371-8
3 Welsh JB, et al. Diabetes Technol Ther 2019;21:128-32.

Exceptional performance and accuracy1

What's the difference between Continuous Glucose Monitoring (CGM) and Flash Glucose Monitoring (FGM)?
There are significant differences between the Dexcom G6 CGM System and the Abbott Freestyle Libre FGM System.
Continuous Glucose Monitoring(Person can see glucose values continuously) Flash glucose monitoring(Person must scan to see glucose values)
System Name Dexcom G64 Freestyle Libre & Librelink5
Indicated for Persons aged 2 years and older Adults aged 18 years and older
Continuous data visibility Yes No
Approved sensor placement Belly/abdomen (ages 2 years and older) or the upper buttocks (ages 2 to 17 years) Back of the arm
Can you make treatment decisions without fingerstick confirmation? Yes
Except fingerstick is required:
• When symptoms do not match sensor readings
• When G6 doesn’t show a number, arrow, or both
Yes
Except fingerstick is required:
• During times of rapidly changing glucose levels
• To confirm hypoglycemia
• To confirm impending hypoglycemia
• When symptoms do not match sensor readings
Customizable real-time low/high glucose alerts Yes No
Calibration (with fingerstick) • No fingerstick calibration required.
• Sensor-code calibrated but optional calibrations are allowed.
No calibration allowed
Approved length of sensor wear Up to 10 days Up to 14 days
Display option Smartphone§, smart watch§, standalone receiver (optional) Smartphone6, standalone reader
Continuous remote monitoring by family or caregiver Yes by using the Follow app4 on a smartphone§ Shared readings occur when the user physically scans using Freestyle Librelink on a smartphone7 and the follower uses the LibreLinkUp app
Water resistant Up to 24 hours in 2.4 meters (8 ft) Up to 30 minutes in 1 meter (3 ft)
Acetaminophen interference7 No8 No
Private insurance coverage Yes, but depends on the individual plan Yes, but depends on the individual plan

Dexcom CGM Outperformed FGM in High-Risk T1D Patients9,10

In patients with Impaired Awareness of Hypoglycemia (IAH) and/or recent severe hypoglycemia, Dexcom CGM
outperformed Flash Glucose Monitoring (FGM) across all hypoglycemia outcomes:
Reduced Overall
Hypoglycemia
Reduced Nighttime
Hypoglycemia
Reduced Fear of
Hypoglycemia
After switching from FGM to Dexcom CGM, participants experienced:
Increased Time in Target Range
(3.9-10.0mmol/L)
Reduced Overall Nighttime Hypoglycemia
(<3.9mmol/L)

What is CGM?

CGM gives users a more complete picture of their glucose levels and trends. Unlike a blood glucose meter which provides just a single reading with each fingerstick, CGM shows patients where their glucose is going and how fast.

Patient Benefits

Despite their best intentions and efforts, many diabetes patients struggle to maintain optimal glycemic control.

Proven Outcomes

A growing amount of evidence substantiates the efficacy of Dexcom Continuous Glucose Monitoring (CGM) Systems for insulin-using patients with Type 1 or Type 2 diabetes.
Keep up with the latest news and information.

Stay up-to-date
with Dexcom

Sign up to stay up-to-date with the latest CGM news, product updates and educational events.
† Requires the Follow App and an internet connection. Followers should always confirm readings on the Dexcom G6 App or Receiver before making treatment decisions.
§ For a list of compatible devices, please visit dexcom.com/compatibility. Use of the smart watch requires the Dexcom G6 App on a compatible smartphone.
1 Shah VN, et al. Diabetes Technol Ther 2018;20:428-33.
2 Beck RW, et al. JAMA. 2017;317:371-8
3 Welsh JB, et al. Diabetes Technol Ther 2019;21:128-32.
4 Using Your G6 Guide
5 Freestyle Libre User Guide & Freestyle LibreLink User Guide
6 Freestyle Librelink Smartphone Compatibility Guide
7 As outlined in respective user guides
8 Calhoun P, et al. J Diabetes Sci Technol 2018;12(2):393-6.
9 Reddy M, et al. Diabet Med 2018;35:483–90
10 Reddy M, et al. Diabetes Technol Ther 2018;20:751–57.